menu

Medical Program: FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19

close
FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The US Food and Drug Administration has authorized clinicians to prescribe chloroquine and hydroxychloroquine for hospitalized patients with COVID-19, despite warnings from scientific advisers that no randomized controlled trial has been conducted to support the drugs’ safety and efficacy in this population.  Pharmacist Dr. Linda Bernstein takes us through the FDA’s decision process, the parameters of the issuance, and comments made by the experts on this emergency ruling.                                                       

    Published April 24, 2020

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The US Food and Drug Administration has authorized clinicians to prescribe chloroquine and hydroxychloroquine for hospitalized patients with COVID-19, despite warnings from scientific advisers that no randomized controlled trial has been conducted to support the drugs’ safety and efficacy in this population.  Pharmacist Dr. Linda Bernstein takes us through the FDA’s decision process, the parameters of the issuance, and comments made by the experts on this emergency ruling.                                                       

    Published April 24, 2020

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/12/20